Profile	GDS4460 / 231262_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	52.3	58
GSM803589	patient 7, baseline	91.8	66
GSM803592	patient 8, baseline	14.4	29
GSM803595	patient 10, baseline	100.6	67
GSM803598	patient 11, baseline	2.2	10
GSM803601	patient 12, baseline	9.5	23
GSM803604	patient 13, baseline	28.2	47
GSM803607	patient 14, baseline	24.6	42
GSM803610	patient 15, baseline	28.7	46
GSM803613	patient 16, baseline	1.4	4
GSM803587	patient 6, arm treated with pimecrolimus	43.6	55
GSM803590	patient 7, arm treated with pimecrolimus	164.2	75
GSM803593	patient 8, arm treated with pimecrolimus	23.6	40
GSM803605	patient 13, arm treated with pimecrolimus	24.8	44
GSM803608	patient 14, arm treated with pimecrolimus	57.4	59
GSM803599	patient 11, arm treated with pimecrolimus	27.1	45
GSM803611	patient 15, arm treated with pimecrolimus	63.6	61
GSM803614	patient 16, arm treated with pimecrolimus	14.5	33
GSM803602	patient 12, arm treated with pimecrolimus	107.2	69
GSM803596	patient 10, arm treated with pimecrolimus	208.1	79
GSM803591	patient 8, arm treated with betamethasone	12.1	29
GSM803609	patient 15, arm treated with betamethasone	143.9	73
GSM803597	patient 11, arm treated with betamethasone	96.7	67
GSM803585	patient 6, arm treated with betamethasone	74.7	62
GSM803603	patient 13, arm treated with betamethasone	127.5	72
GSM803612	patient 16, arm treated with betamethasone	59.4	58
GSM803588	patient 7, arm treated with betamethasone	247.6	81
GSM803594	patient 10, arm treated with betamethasone	223.2	80
GSM803600	patient 12, arm treated with betamethasone	190	78
GSM803606	patient 14, arm treated with betamethasone	330.1	85